Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
JanOne Inc. (ARCI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
8-K
| Quarterly results |
| 08/24/2023 |
SC 13G/A
| BIGGER CAPITAL FUND L P reports a 3.9% stake in JanOne Inc. |
| 08/23/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 08/22/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/16/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/15/2023 |
10-Q
| Quarterly Report for the period ended July 1, 2023 |
| 07/07/2023 |
8-K/A
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 06/30/2023 |
8-K
| Changes in Registrant's Certifying Accountant Interactive Data |
| 05/11/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/25/2023 |
10-Q/A
| Quarterly Report for the period ended July 2, 2022 [amend] |
| 04/25/2023 |
10-Q/A
| Quarterly Report for the period ended October 1, 2022 [amend] |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/27/2023 |
SC 13G
| BIGGER CAPITAL FUND L P reports a 9.9% stake in JanOne, Inc. |
| 03/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
". IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.",
"JanOne Technologies Announces Registered Direct Offering of Common Stock Priced At-The-Market LAS VEGAS, March 23, 2023 /PRNewswire/ -- JanOne , a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 361,000 shares of the Company’s common stock at a purchase price of $1.17 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about March 24, 2023, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds t...",
"JanOne Technologies Announces Closing of Registered Direct Offering of Common Stock Priced At-The-Market LAS VEGAS, March 24, 2023 /PRNewswire/ -- JanOne , a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced the closing of its previously announced registered direct offering of 361,000 shares of the Company’s common stock at a purchase price of $1.17 per share of common stock priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering were approximately $422,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the ne..." |
|
| 03/24/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/24/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/21/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 03/20/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 02/13/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
8-K
| Quarterly results |
| 01/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ... |
| 11/25/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended October 1, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 10/06/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/30/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended July 2, 2022 |
| 06/28/2022 |
8-K
| Quarterly results |
| 05/31/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended April 2, 2022 |
| 04/15/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 04/01/2022 |
10-K
| Annual Report for the period ended January 1, 2022 |
|
|
|